---
search:
  boost: 2 
---

# NSAIDs

This is a subcategory of Analgesic Agents.

## Decision Tree

- [Analgesic Agents - NSAID](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?origin=OfficeDotCom&lang=en-US&sessionid=dba554c2-2c78-4f60-bee3-f837172c2546&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBURVE2VUlEMVVWSFZVRjNHWUhSWEFIVlVDWiQlQCN0PWcu&topview=Preview){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                   | Generic Name                              | Quantity | Time (Days) |
|:----------------------------|:------------------------------------------|:--------:|:-----------:|
| Celecoxib <sup>QL</sup>     | Celecoxib Cap (all strengths excl 400 MG) |    68    |     34      |
| Celecoxib <sup>QL</sup>     | Celecoxib Cap 400 MG                      |    34    |     34      |
| Diclofenac IR               |                                           |          |             |
| Diclofenac DR               |                                           |          |             |
| Diclofenac ER               |                                           |          |             |
| Diclofenac Gel 1%           |                                           |          |             |
| Etodolac                    |                                           |          |             |
| Fenoprofen 600mg            |                                           |          |             |
| Flurbiprofen                |                                           |          |             |
| Ibuprofen                   |                                           |          |             |
| Indocin                     |                                           |          |             |
| Indomethacin                |                                           |          |             |
| Ketoprofen ER               |                                           |          |             |
| Ketorolac                   |                                           |          |             |
| Meclofenamate               |                                           |          |             |
| Mefenamic Acid              |                                           |          |             |
| Meloxicam Tab               |                                           |          |             |
| Nabumetone                  |                                           |          |             |
| Naproxen IR                 |                                           |          |             |
| Naproxen Susp <sup>AR</sup> |                                           |          |             |
| Oxaprozin                   |                                           |          |             |
| Piroxicam                   |                                           |          |             |
| Sulindac                    |                                           |          |             |

### Non-Preferred

| Non-Preferred                                | Generic Name | Quantity | Time (Days) |
|:---------------------------------------------|:-------------|:--------:|:-----------:|
| Diclofenac / Misoprostol                     |              |          |             |
| Diclofenac Patch Gel 3%, Patch 1.3%, Soln 2% |              |          |             |
| Diclotrex                                    |              |          |             |
| Elyxyb                                       |              |          |             |
| Fenoprofen 400mg                             |              |          |             |
| Ibuprofen / Famotidine                       |              |          |             |
| Ketorolac Tromethamine Nasal Spray           |              |          |             |
| Ketoprofen                                   |              |          |             |
| Licart Patch                                 |              |          |             |
| Meloxicam Cap                                |              |          |             |
| Naproxen CR                                  |              |          |             |
| Naproxen DR                                  |              |          |             |
| Naproxen ER                                  |              |          |             |
| Naproxen EC                                  |              |          |             |
| Naproxen / Esomeprazole                      |              |          |             |
| Pennsaid <sup>BvG</sup>                      |              |          |             |
| Qmiiz ODT                                    |              |          |             |
| Relafen DS                                   |              |          |             |
| Zorvolex                                     |              |          |             |

## Authorizations

**Length of Authorizations**: Dependent upon the table below

|                      | Authorization Length |
|:--------------------:|:--------------------:|
| H. Pylori Treatment  |       30 days        |
| Transdermal/Topical  |       90 days        |
| All Other Treatments |       365 days       |

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Non-Preferred

Non- Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR** 
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **30 days** with at least **two preferred** drugs 
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available) 
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available) 

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

**AR** - Naproxen Suspension: a PA is required for patients 12 years and older

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_Criteria%20_APPROVED.pdf#page=9){ :target="_blank" rel="noopener"}

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_v7_Approved.pdf#page=8){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf#overlay-context=drug-coverage){ :target="_blank" rel="noopener"}
